Forbes Magazine Names Mesa Labs among Best Companies in the U.S.

Top Quote Company climbs up four positions from last year's annual index of best small public companies in America. End Quote
  • Denver, CO (1888PressRelease) October 12, 2013 - Colorado-based Mesa Laboratories, Inc. (Nasdaq: MLAB) was ranked #45 on Forbes magazine's annual list of 100 best small companies in America. The company, which manufactures a range of quality control instruments for healthcare and industry, moved up from #49 in last years rating.

    Mesa Labs topped the three Colorado companies that made the list, followed by Air Methods Corp., and Innospec, Inc.

    "It is great to be recognized by Forbes again this year as one of the Country's top performing small public companies. This recognition is a testament to the hard work and dedication put forward by every employee here at Mesa", said Mesa Labs CEO John Sullivan.

    "We moved up from number 49 of the top 100 last year, to number 45 this year, largely due to the addition of the revenue and profitability from our 2012 acquisition of the Bios flow calibrator product line. We look forward to another good year at Mesa and the opportunity to be recognized again by Forbes", he added.

    The Forbes list ranks companies with sales under $1 billion by overall growth and return on equity. Over the last two years, Mesa Labs' stock has seen steady growth and they have completed two successful acquisitions which likely contributed to their improved ranking.

    About Mesa Laboratories, Inc.
    We pursue a strategy of focusing primarily on quality control products, which are sold into niche markets that are driven by regulatory requirements. We prefer markets that have limited competition where we can establish a commanding presence and achieve high gross margins. We are organized into two divisions across four physical locations. Our Instruments division designs, manufactures and markets quality control instruments and disposable products utilized in connection with the healthcare, pharmaceutical, food and beverage, medical device, industrial hygiene, semiconductor and petrochemical industries. Our Biological Indicators division manufactures and markets biological indicators and distributes chemical indicators used to assess the effectiveness of sterilization processes, including steam, gas, hydrogen peroxide and radiation, in the hospital, dental, medical device and pharmaceutical industries

    Forward Looking Statements

    This press release may contain information that constitutes "forward-looking statements." Generally, the words "believe," "expect," "intend," "estimate," "anticipate," "project," "will" and similar expressions identify forward-looking statements, which generally are not historical in nature. However, the absence of these words or similar expressions does not mean that a statement is not forward-looking. All statements that address operating performance, events or developments that we expect or anticipate will occur in the future - including statements relating to revenue growth and statements expressing general views about future operating results - are forward-looking statements.

    Management believes that these forward-looking statements are reasonable as and when made. However, caution should be taken not to place undue reliance on any such forward-looking statements because such statements speak only as of the date when made. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. In addition, forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from our historical experience and present expectations or projections. These risks and uncertainties include, but are not limited to, those described in our Annual Report on Form 10-K for the year ended March 31, 2013, and those described from time to time in our subsequent reports filed with the Securities and Exchange Commission.

  • FB Icon Twitter Icon In-Icon
Contact Information